RAF413: GLP-1 Weight Loss Drugs - Wegovy, Ozembic, Zepbound and Others
On June 4, 2021, the FDA approved Wegovy for the treatment of chronic obesity and overweight individuals. Dr. John Sharretts, deputy director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDA's Center for Drug Evaluation and Research, said, "Today's approval offers adults with obesity or overweight a beneficial new treatment option to incorporate into a weight management program. FDA remains committed to facilitating the development and approval of additional safe and effective therapies for adults with obesity or overweight."
Read the full post at…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.